|Bid||201.95 x 1400|
|Ask||807.77 x 800|
|Day's Range||494.67 - 494.67|
|52 Week Range||465.00 - 818.60|
|Beta (5Y Monthly)||0.92|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for BIO-B
In this article, we discuss the 10 biotech stocks that investors are watching. If you want to read about some more biotech stocks, go directly to Investors are Watching These 5 Biotech Stocks. The stock market plunge in the past few weeks because of soaring inflation and a hawkish central bank has also resulted in […]
HERCULES, Calif., June 27, 2022--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today released its inaugural corporate sustainability report.
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...